Welcome to our dedicated page for Iveda Solutions SEC filings (Ticker: IVDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Iveda Solutions, Inc. filings document the company's public-company reporting as a Delaware corporation focused on AI video surveillance, smart city technologies, and IoT platforms. Registration statements and amendments describe securities offerings, capital structure, operating and financial results, and risk disclosures tied to the company's technology business.
Current reports cover material events including Nasdaq continued-listing notices, stockholders' equity compliance, minimum bid-price matters, and registered securities consisting of common stock and common stock purchase warrants. Proxy materials document annual meeting matters such as director elections, auditor ratification, shareholder voting mechanics, and governance procedures.
Iveda Solutions reported Q1 2026 revenue of $1.49 million, up slightly from $1.47 million a year earlier, driven mainly by higher Taiwan government project sales. Gross profit rose to $0.50 million, improving margin as cost of revenue fell. The company still posted a net loss of $0.53 million, narrower than the prior-year loss of $0.79 million, and used $0.9 million of cash in operations.
During the quarter Iveda raised net proceeds of about $1.6 million through a February 2026 equity offering, doubling common shares outstanding to 11.6 million and ending the period with $5.7 million in cash. Management concluded this cash should fund the operating plan for at least 12 months, though the company continues to carry an accumulated deficit and relies heavily on a few large Taiwan customers. Internal control over financial reporting and disclosure controls were assessed as not effective due to material weaknesses, which management is working to remediate.
Iveda Solutions disclosure of beneficial ownership by Iroquois Capital Management, Richard Abbe and Kimberly Page. The filing reports each Reporting Person as beneficially owning 585,068 shares of Common Stock, reflecting shares issuable upon exercise of warrants that are subject to 4.99% Beneficial Ownership Blockers. The Form 10-K shows 11,139,740 shares outstanding as of March 15, 2026, and the warrants described are exercisable for up to 1,000,000 and 428,572 shares respectively but cannot be exercised beyond the 4.99% limit.
Iveda Solutions, Inc. files a Prospectus Supplement No. 14 dated April 1, 2026 that updates its August 30, 2022 prospectus to include the company’s Annual Report on Form 10-K for the period ended December 31, 2025 (filed March 31, 2026). The supplement covers registration language for 138,759 shares of common stock, warrants to purchase up to 411,185 shares of common stock at an exercise price of $11.20, and pre-funded warrants to purchase up to 273,685 shares of common stock, and incorporates the Form 10-K by reference.
The supplement is qualified by reference to the underlying prospectus and is intended to be read together with it, including its "Risk Factors" section. This document does not itself change offering terms; it adds the Form 10-K information to the existing prospectus package.
Iveda Solutions, Inc. files a Prospectus Supplement No. 14 to the March 31, 2022 prospectus to include its Form 10-K and to cover warrants to purchase 235,625 shares of common stock at a strike price of $34.00 per share held by stockholders identified in the prospectus.
Iveda Solutions, Inc. registers primary securities for sale. The prospectus supplement registers 5,259,999 shares of Common Stock, up to 5,714,286 Series X Warrants to purchase up to 11,428,572 shares of Common Stock, and up to 400,000 Placement Agent Warrants to purchase up to 400,000 shares. The supplement incorporates the company's Form 10-K for the period ended December 31, 2025 and updates the Prospectus effective February 9, 2026.
Iveda Solutions, Inc., now a Delaware corporation listed on Nasdaq, reports continued operating losses while positioning itself as an AI-driven smart city and IoT platform provider. For the year ended December 31, 2025, it recorded a net loss of about $3.2 million, following a $4.0 million loss in 2024, and has accumulated losses of roughly $56 million.
The company depends heavily on its Taiwan subsidiary, which generated 85% of 2025 revenue and 87% of 2024 revenue, and on a small number of large customers; four customers made up 63% of 2025 revenue. Iveda offers AI video analytics (IvedaAI), IoT platforms (Cerebro), smart power solutions, smart poles, drones, health and elder-care devices, and industrial monitoring tools.
As of March 15, 2026, Iveda had 11,139,740 shares of common stock outstanding and significant U.S. net operating loss carryforwards of about $40.0 million federal and $11.0 million state. The company highlights risks from ongoing losses, reliance on key personnel, geopolitical uncertainty around Taiwan, cybersecurity gaps, and potential Nasdaq listing compliance issues.
Iveda Solutions, Inc. has been notified by Nasdaq that its common stock no longer meets the exchange’s minimum bid price requirement of $1 per share, after trading below that level for 30 consecutive business days. The notice does not immediately affect the stock’s Nasdaq listing.
The company has 180 calendar days, until September 2, 2026, to regain compliance. Nasdaq will deem the requirement met if the closing bid price is at least $1 for a minimum of ten consecutive business days during this period. If compliance is not restored or other listing rules are breached, Nasdaq may move to delist the shares, although Iveda could appeal any delisting determination to a Nasdaq Hearings Panel.
Iveda Solutions director Robert Gillen reported offsetting option transactions tied to an option repricing. He was granted 100,000 stock options on an "acquire" transaction and disposed of 100,000 options back to the issuer on a separate "disposition to issuer" transaction, leaving 128,599 options reported as held afterward.
According to a board-approved repricing on February 23, 2026, his options were reset to an exercise price of $0.29 per share while all other terms remained unchanged. The company states these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.
Iveda Solutions Chief Financial Officer Robert J. Brilon reported changes to his stock options in a paired, non-cash transaction. He was granted 125,000 options and disposed of 125,000 options, both recorded as “Options (Right to Buy).” Following these transactions, he holds 152,503 derivative securities directly.
The company’s board approved an option repricing on February 23, 2026, resetting the exercise price of his options to $0.29 per share. The filing states that all other option terms remain unchanged and that the repricing was exempt under specific Exchange Act rules.
Iveda Solutions director Franco Alejandro reported an option repricing and related award. On February 23, 2026, the board approved a repricing of his options to an exercise price of $0.29 per share, with all other terms unchanged. This involved an acquisition of 25,000 options and a corresponding disposition of 25,000 options to the issuer, both recorded at a transaction price of $0.00 per option. Following these transactions, Alejandro directly held 53,130 options to acquire Iveda Solutions stock. The company notes these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.